期刊文献+

两亲性壳聚糖包覆紫杉醇脂质体的制备及体外释放研究 被引量:2

Preparation and in vitro Release of Paclitaxel Loaded Liposomes Modified with Amphiphilic Chitosan Derivatives
下载PDF
导出
摘要 目的:制备两亲性壳聚糖N-辛基-N,O-羧甲基壳聚糖包覆紫杉醇脂质体(PTX-LP-OCC),并考察其理化性质及体外释放行为。方法:采用基于乙醇的前体脂质体法制备紫杉醇脂质体并以OCC包覆,并以普通脂质体(PTX-LP)为对照,测定其包封率、粒径大小、电位,观测其形态及稳定性,然后采用全体液平衡反向透析法研究体外释放行为。结果:紫杉醇脂质体包封率为89.5%,粒径为236.5 nm,Zeta电位为-31.4 mV,多糖包覆修饰后药物包封率无显著变化,粒径及Zeta电位显著增加,脂质体稳定性显著提高,药物释放呈缓释特征,且突释显著降低。 Objective: To prepare paclitaxel loaded liposomes modified with amphiphilic chitosan deirvatives (N-octyl-N,O-carboxymethyl chitosan, OCC), and investigate their characteristics and release behavior in vitro. Methods: Paclitaxel loaded liposomes modified with or without OCC (PTX-LP, PTX-LP-OCC) were prepared using an ethanol-based proliposome technology. Particle size and zeta potential of the liposomes were determined with Zetasizer 3000 HSa. The morphology was observed by a transmission electron microscope (TEM) technology. Stability of liposomes was evaluated by determining the particle size and drug leakage from liposomes. Finally, the in vitro release profiles of paclitaxel from PTX-LP and PTX-LP-OCC were evaluated using the bulk-equilibrium reverse dialysis bag technique. Results: Paclitaxel loaded liposomes were successfully prepared with an average diameter of 236.5 nm and zeta potential of -31.4 mV. The encapsulation efficiency was 89.5%. After OCC modification, there was no significant change in encapsulation efficiency, but the particle size and zeta potential significantly increased. As compared to PTX-LP, PTX-LP-OCC possessed better stability and lower burst release. Conclusion: Liposome modified with amphiphilic chitosan derivatives is a promising carrier for anticancer drug delivery.
出处 《药学与临床研究》 2012年第6期490-494,共5页 Pharmaceutical and Clinical Research
关键词 两亲性壳聚糖 脂质体 紫杉醇 药物泄漏 体外释放 Amphiphilic chitosan Liposome Paclitaxel Drug leakage In vitro release
  • 相关文献

参考文献13

  • 1Yoncheva K, Calleja P, Agaeros M, et al. Slabilized micelles as delivery vehicles fir pacli/axel [J]. lnt J Pharm, 2012. 436(1-2): 258-64. 被引量:1
  • 2Pham AQ, Bcrz D, Karwan P, et al. Cremophor-in- duced lupus erythematosus-like reaction with taxol ad- ministration: a case report and review of tile literature [J]. Cae Rep OTwol, 2011, 4(3): 526-30. 被引量:1
  • 3雷景邦,刘旭海,万瑾瑾,叶民珠,邹富有.注射用紫杉醇纳米制剂的研究进展[J].中国新药与临床杂志,2010,29(6):406-409. 被引量:11
  • 4净晓龙,陈建明.紫杉醇给药系统的研究进展[J].中国新药与临床杂志,2011,30(9):650-657. 被引量:11
  • 5Kumar P, Gulbake A, Jain SK. l,iposomes a vesicular nanocarrier: potential advaneements in cancer chemotherapy [J]. Crit Rev Ther Drug Carrier ,r'st, 2012, 29(5): 355-419. 被引量:1
  • 6Bernkop-Schntirch A, D.innhaupt S. Chitosan-based drug delivery systems[J]. Eur J Pharm Biopharm, 2012, 81 (3): 463-9. 被引量:1
  • 7陈新梅.壳聚糖包覆的人参皂苷Rg3脂质体的制备及质量评价[J].中国现代药物应用,2011,5(3):4-5. 被引量:1
  • 8Kowapradit J, Apirakaramwong A, Ngawhimnpat T, et al. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivel'[J]. Eur J Pharm Sci, 2012, 47(2): 359-66. 被引量:1
  • 9Goncalves MC, Mertins O, Pohlmann AR, et al. Guterres SS. Chitosan coated liposomes as an innovative nanocarrier for drugs[J]. J Biomed N<motechnol, 2012, 8 (2): 240-50. 被引量:1
  • 10周建平,全新勇,谭燕,等.一种紫杉醇自组装前体脂质体及其制备方法[P].中国专利授权号CN100563715C. 被引量:1

二级参考文献94

共引文献55

同被引文献30

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部